Your session is about to expire
← Back to Search
Arm 2 - Intervention for Swallowing Difficulty (ESSI-SURG Trial)
ESSI-SURG Trial Summary
This trial will examine whether early and systematic speech and swallowing therapy with speech-language pathologists can help improve the health and function of patients with oral cavity cancer, specifically tongue cancer, who are undergoing surgery.
ESSI-SURG Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowESSI-SURG Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ESSI-SURG Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are participants currently being recruited for this ongoing study?
"Indeed, the information provided by clinicaltrials.gov indicates that this study is actively seeking individuals to participate. The trial was initially posted on December 1st, 2023 and underwent its most recent revision on December 20th, 2023. In total, the trial aims to enroll a cohort of 40 participants at one specific location."
What is the upper limit on the number of individuals participating in this research endeavor?
"Indeed, according to the details provided on clinicaltrials.gov, this study is currently in the recruitment phase. It was initially posted on December 1st, 2023 and last updated on December 20th, 2023. The trial aims to enroll a total of 40 participants from a single site."
Share this study with friends
Copy Link
Messenger